Efficient IC Process and Anaerobic Solutions for Pharmaceutical Wastewater Treatment Projects in Malaysia

The pharmaceutical industry in Malaysia is currently positioned as a high-growth strategic sector, driven by the government’s push to become a regional hub for generic pharmaceutical manufacturing and Halal-certified pharmaceuticals. With the expansion of industrial parks in states like Selangor and Johor, local manufacturing capacity is reaching new heights. However, this industrial progress brings significant environmental responsibilities. Managing complex manufacturing effluent has become a top priority for local producers.

As a premier global EPC contractor, Center Enamel specializes in delivering high-efficiency Anaerobic Solutions, particularly the Internal Circulation (IC) process, to help Malaysian enterprises transform wastewater challenges into sustainable operational success.

Malaysia’s Pharmaceutical Industry and Environmental Policy

Malaysia’s pharmaceutical sector is characterized by a strong mix of domestic companies and multinational corporations. To support this growth while protecting the country's diverse ecosystems, the Department of Environment (DOE) enforces strict regulations under the Environmental Quality Act 1974. Specifically, the Environmental Quality (Industrial Effluent) Regulations 2009 set rigorous limits on discharge parameters.

For pharmaceutical plants, the pressure to comply with "Standard A" or "Standard B" discharge limits—depending on the location relative to water intake points—is immense. Failure to meet these standards can lead to severe penalties, making advanced Pharmaceutical Wastewater Treatment Projects a fundamental necessity for business continuity and legal compliance in Malaysia.

Challenges of Pharmaceutical Manufacturing Wastewater

Pharmaceutical manufacturing produces wastewater that is among the most difficult to treat biologically. While municipal sewage primarily consists of biodegradable organic matter from domestic sources like kitchens and bathrooms, industrial manufacturing effluent is far more complex:

High Toxicity: The presence of residual antibiotics, active pharmaceutical ingredients (APIs), and specialized solvents can be lethal to the microbial populations used in standard biological treatment.

Extreme Organic Loading: Effluents often feature exceptionally high levels of Chemical Oxygen Demand (COD) and Biological Oxygen Demand (BOD) that can overwhelm conventional systems.

Variable Salinity and pH: Frequent changes in production cycles result in inconsistent wastewater quality, creating "shock loads" that can destabilize traditional treatment plants.

Comprehensive Pharmaceutical Wastewater Treatment Flow

To handle these complexities, Center Enamel implements a scientifically structured, high-performance treatment flow:

Pre-treatment: Physical screening, grit removal, and pH adjustment are used to stabilize the raw effluent before it enters biological stages.

Anaerobic Core: This is the most critical stage. High-rate reactors like IC or UASB are used to break down the bulk of the high-strength organic matter into biogas.

Aerobic Polishing: Following anaerobic treatment, aerobic processes remove residual COD and nutrients through oxidation.

Advanced Filtration & Disinfection: Technologies such as membranes or activated carbon ensure the water meets the strictest DOE discharge standards for safe release or potential reuse.

Core Anaerobic Technologies: IC, UASB, CSTR, and USR

Center Enamel integrates a suite of specialized anaerobic technologies tailored to the specific needs of each pharmaceutical project:

IC (Internal Circulation) Reactor: This next-generation high-rate reactor uses a unique two-stage anaerobic process. It circulates sludge internally, allowing it to handle significantly higher organic loads while providing superior stability against the shock loads common in pharmaceutical production.

UASB (Upflow Anaerobic Sludge Blanket): A globally recognized high-rate solution. It treats liquid-phase sewage by passing it through a dense blanket of anaerobic sludge, offering high efficiency in a compact footprint.

CSTR (Continuous Stirred Tank Reactor): Ideal for wastewater with high suspended solids (SS). Mechanical stirring ensures uniform contact between the waste and microorganisms, preventing sedimentation issues.

USR (Upflow Solids Reactor): Specifically engineered for effluents with very high solid content, the USR ensures that organic particles are fully digested and converted into energy.

The Advantage of Glass-Fused-to-Steel (GFS) Tanks

Center Enamel’s EPC solutions utilize proprietary Glass-Fused-to-Steel (GFS) tanks as the primary containment vessels. These tanks offer decisive benefits over traditional concrete for the Malaysian climate:

Superior Corrosion Resistance: The glass-to-steel bond is chemically inert and impervious to the aggressive organic acids and chemicals found in pharmaceutical waste.

Rapid Modular Installation: Malaysia’s frequent tropical rainfall can delay concrete construction. GFS tanks are bolted together quickly on-site, drastically reducing project timelines and minimizing factory downtime.

Flexibility and Longevity: With a service life of over 30 years, these tanks can be easily expanded or even relocated as a manufacturer's production capacity grows.

Why Choose Center Enamel as Your EPC Partner?

Choosing Center Enamel means partnering with a global leader that offers a seamless, turnkey experience:

Customized Engineering: We provide precision-designed systems tailored to the specific chemical footprint and effluent standards of your Malaysian facility.

Proven Global Expertise: With successful projects in over 100 countries, we bring international engineering excellence to Malaysia’s local pharmaceutical sector.

Full Lifecycle Support: From initial process design and GFS tank fabrication to automated control systems and long-term commissioning, we handle every detail.

Success Stories in Pharmaceutical Wastewater Treatment

Case 1: Zhejiang Pharmaceutical Plant Wastewater Treatment Project

Process: IC

Tank Dimensions: φ12.66 × 24 m (H) — 6 Units

Total Tank Volume: 18,114 m³

Completion Date: 2019

Case 2: Jiangsu Pharmaceutical Wastewater Treatment Project

Process: CSTR

Tank Dimensions:

φ10.7 × 16.8 m (H) — 2 Units

φ7.64 × 3.6 m (H) — 2 Units

φ5.35 × 3.6 m (H) — 4 Units

φ3.82 × 3.6 m (H) — 2 Units

Total Tank Volume: 3,748 m³

Completion Date: 2021

As Malaysia’s pharmaceutical industry moves toward higher environmental standards and sustainable growth, the need for advanced wastewater solutions is critical. Center Enamel’s integration of the IC process and Glass-Fused-to-Steel technology provides manufacturers with a future-proof foundation for environmental compliance. By selecting a professional EPC partner with specialized anaerobic expertise, Malaysian pharmaceutical companies can effectively protect local water resources while ensuring their long-term economic competitiveness in the global market.